Qiagen ($QGEN) warned of a fourth quarter and full

Qiagen ($QGEN) warned of a fourth quarter and full year shortfall, citing volatility in the timing of revenues from its companion diagnostic partnerships and lower revenues from instruments. The company now expects 3 percent growth in adjusted net sales, down from the 4 percent growth it estimated earlier. At actual currency rates, the company expects a 5 percent drop in adjusted net sales to $1.28 billion and adjusted earnings of $1.05-$1.06 per share.